Search Browse Earnings

Nuo Therapeutics, Inc.

OTC:AURX

Surgical & Medical Instruments & Apparatus·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Jorden David Emerson

Revenue

$472,445

+0.0% YoY

FY 2017

Adj. EBITDA

-$3.1M

-651.6% margin

FY 2024

Net Income

-$3.2M

-671.3% margin

FY 2024

EPS (Diluted)

-$0.05

FY 2021

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$2.1M

FY 2024

Total Debt

$1.8M

FY 2021

Net Cash

$251,208

FY 2021

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2017

EV / EBITDA

—

Employees

—